Hyperion Defi Inc (HYPD)

$3.97 +0.36 (9.97%)
Market Cap 31.66M
Revenue (ttm) 60,000.00
Net Income (ttm) -49.82M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -83,033.33%
Debt to Equity Ratio 0.11
Volume 408,123
Avg Vol 529,766
Day's Range N/A - N/A
Shares Out 8.10M
Stochastic %K 7%
Beta 2.80
Analysts Strong Buy
Price Target N/A

Company Profile

Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in Chin...

Industry: Biotechnology
Sector: Healthcare
Phone: 917 289 1117
Address:
295 Madison Avenue, Suite 2400, New York, United States
Sgershon88
Sgershon88 Dec. 4 at 5:59 PM
$HYPD For anyone not completely sure about the $HYPD (Dat) strategy or hyperliquid in general... Go do some research on $PURR.X which just went public yesterday. Over $800M devoted to buying and staking Hype coin... This is coming from someone that initially came into this company due to my interest in $EYEN. Got killed there obv, but have not sold my position and am now incredibly bullish on Hype.
0 · Reply
_www_larval_com_
_www_larval_com_ Dec. 4 at 3:27 PM
Look $HYPD has jumped 8% higher to 5% (~83Kv) moments ago, follow for more volatility.
0 · Reply
topstockalerts
topstockalerts Dec. 4 at 2:58 PM
Hyperion DeFi received nearly 2 million KNTQ tokens in a recent airdrop tied to Kinetiq’s token event. While noting limited trading history and expected volatility, the company cited a $0.145 trading price for KNTQ on December 3. Hyperion also secured rights to stake 28,888 HYPE tokens on the Kinetiq decentralized exchange and earn 10% of proportional fee revenue. It announced a partnership with Native Markets to support USDH, Hyperliquid’s native stablecoin, allocating 300,000 HYPE—its third DeFi monetization deal, expected to deliver returns above traditional staking. The company purchased an additional 150,000 HYPE, lifting its total holdings to 1.86 million, and expects adjusted revenue growth of 31% to 43% in Q4, with positive operating cash flow anticipated in 2026. $HYPD
0 · Reply
Diiiii
Diiiii Dec. 4 at 2:05 PM
$HYPD Something I've written about here several times has now been officially announced. Airdrop received at KNTQ's TGE. Although the share price continues to fall, I am once again convinced that HYPD will eventually become many times its current value.
0 · Reply
Pomer_Gile1
Pomer_Gile1 Dec. 4 at 2:05 PM
$HYPD Can anyone explain to me what this company actually does? Explain it as simply as possible
0 · Reply
Jwa68
Jwa68 Dec. 4 at 1:06 PM
$HYPD Nice news just out. https://www.globenewswire.com/news-release/2025/12/04/3199732/0/en/Hyperion-DeFi-Announces-Receipt-of-Kinetiq-Airdrop-Partnership-with-Native-Markets-and-Purchase-of-150-000-Additional-HYPE.html
0 · Reply
Jwa68
Jwa68 Dec. 3 at 11:59 PM
$HYPD https://www.linkedin.com/posts/ccndotcom_get-ready-for-our-next-interview-from-ugcPost-7401944359350448128-ZUGx?utm_source=share&utm_medium=member_android&rcm=ACoAAAEYKlkB4RqKdjXjN7IGB2MIOkTwWTUEzek
0 · Reply
URANIO_ARRICCHITO
URANIO_ARRICCHITO Dec. 3 at 9:03 PM
$HYPD The question is: 'Why ?'
1 · Reply
YorkMeister
YorkMeister Dec. 3 at 5:27 PM
$HYPD no SP volume, just silence, no buys of HYPX(?). If this wants to be a good proxy for investing in HYPX, it is not doing a good job at the start. Its MC is way below NAV. even after the crypto drop.
1 · Reply
949Jaguar123
949Jaguar123 Dec. 3 at 4:02 PM
$SONN What the deal with this , was at 4 d. couple days ago and now 1.26 , I am not in yet and holding $HYPD
1 · Reply
Latest News on HYPD
Hyperion DeFi, Inc. (HYPD) Q3 2025 Earnings Call Transcript

Nov 14, 2025, 3:41 PM EST - 20 days ago

Hyperion DeFi, Inc. (HYPD) Q3 2025 Earnings Call Transcript

Hyperion DeFi Announces Appointment of David Knox as Chief Financial Officer

Sep 29, 2025, 8:00 AM EDT - 2 months ago

Hyperion DeFi Announces Appointment of David Knox as Chief Financial Officer

Many crypto-treasury companies are trading for less than what their digital assets are worth. Is this a bargain or a big red flag?

Sep 27, 2025, 7:30 AM EDT - 2 months ago

Many crypto-treasury companies are trading for less than what their digital assets are worth. Is this a bargain or a big red flag?

ALTS MARA MSTR

Hyperion DeFi Adds $10M in HYPE to its Treasury Holdings

Sep 25, 2025, 8:00 AM EDT - 2 months ago

Hyperion DeFi Adds $10M in HYPE to its Treasury Holdings

Hyperion DeFi Enters Into First HAUS Agreement With Proprietary Trading Firm Credo

Sep 16, 2025, 8:00 AM EDT - 2 months ago

Hyperion DeFi Enters Into First HAUS Agreement With Proprietary Trading Firm Credo

Kinetiq Announces iHYPE Launch with Hyperion DeFi as First Institutional Depositor

Aug 14, 2025, 10:16 AM EDT - 4 months ago

Kinetiq Announces iHYPE Launch with Hyperion DeFi as First Institutional Depositor

Hyperion DeFi Provides Corporate Update and Reports Second Quarter 2025 Financial Results

Aug 13, 2025, 4:01 PM EDT - 4 months ago

Hyperion DeFi Provides Corporate Update and Reports Second Quarter 2025 Financial Results

Hyperion Defi to Report Second Quarter 2025 Results on Wednesday, August 13, 2025

Aug 8, 2025, 4:05 PM EDT - 4 months ago

Hyperion Defi to Report Second Quarter 2025 Results on Wednesday, August 13, 2025

Hyperion DeFi Purchases Additional $5 Million in HYPE for Kinetiq iHYPE Strategy

Jul 28, 2025, 8:00 AM EDT - 4 months ago

Hyperion DeFi Purchases Additional $5 Million in HYPE for Kinetiq iHYPE Strategy

Hyperion DeFi to Host Corporate Update Event to Discuss Strategic Evolution from Eyenovia and the Future of On-Chain Finance on July 29, 2025

Jul 17, 2025, 8:00 AM EDT - 5 months ago

Hyperion DeFi to Host Corporate Update Event to Discuss Strategic Evolution from Eyenovia and the Future of On-Chain Finance on July 29, 2025

Hyperion DeFi Adds $5 Million in HYPE to its Treasury Holdings

Jul 14, 2025, 4:05 PM EDT - 5 months ago

Hyperion DeFi Adds $5 Million in HYPE to its Treasury Holdings

Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings

Jun 18, 2025, 2:04 PM EDT - 6 months ago

Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings

KIDZ LGHL VVPR

Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group

Jun 18, 2025, 8:32 AM EDT - 6 months ago

Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group

Eyenovia Surges on Crypto Announcement

Jun 17, 2025, 3:54 PM EDT - 6 months ago

Eyenovia Surges on Crypto Announcement

Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy

Jun 17, 2025, 2:55 PM EDT - 6 months ago

Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy

Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results

May 19, 2025, 5:30 PM EDT - 7 months ago

Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results

Eyenovia Provides Development Update on Optejet User Filled Device (UFD)

Apr 10, 2025, 7:00 AM EDT - 8 months ago

Eyenovia Provides Development Update on Optejet User Filled Device (UFD)

Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq

Mar 20, 2025, 7:00 AM EDT - 9 months ago

Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq

Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements

Feb 26, 2025, 7:00 AM EST - 10 months ago

Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements

Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives

Feb 24, 2025, 7:00 AM EST - 10 months ago

Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives

Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device

Feb 5, 2025, 7:00 AM EST - 10 months ago

Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device

Eyenovia Announces 1-for-80 Reverse Stock Split

Jan 28, 2025, 4:05 PM EST - 11 months ago

Eyenovia Announces 1-for-80 Reverse Stock Split

Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders

Jan 15, 2025, 7:00 AM EST - 11 months ago

Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders

Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives

Jan 6, 2025, 7:00 AM EST - 11 months ago

Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives

Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering

Dec 6, 2024, 8:00 AM EST - 1 year ago

Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering

Eyenovia Provides Update on Restructuring Efforts

Nov 22, 2024, 7:00 AM EST - 1 year ago

Eyenovia Provides Update on Restructuring Efforts

Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline

Nov 15, 2024, 1:15 PM EST - 1 year ago

Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline

Eyenovia to discontinue late-stage study for eye drug

Nov 15, 2024, 7:07 AM EST - 1 year ago

Eyenovia to discontinue late-stage study for eye drug

Eyenovia Provides Update on Phase 3 CHAPERONE Study

Nov 15, 2024, 7:00 AM EST - 1 year ago

Eyenovia Provides Update on Phase 3 CHAPERONE Study

Eyenovia, Inc. (EYEN) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 10:42 PM EST - 1 year ago

Eyenovia, Inc. (EYEN) Q3 2024 Earnings Call Transcript

Eyenovia to Report Third Quarter 2024 Results on Tuesday, November 12th

Nov 7, 2024, 7:00 AM EST - 1 year ago

Eyenovia to Report Third Quarter 2024 Results on Tuesday, November 12th

Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo

Oct 16, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo

Eyenovia Announces Commencement of Manufacturing of its Advanced, Second Generation Optejet Device

Oct 1, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Commencement of Manufacturing of its Advanced, Second Generation Optejet Device

Eyenovia, Inc. Announces Pricing of $4 Million Registered Direct Offering

Sep 27, 2024, 8:30 AM EDT - 1 year ago

Eyenovia, Inc. Announces Pricing of $4 Million Registered Direct Offering

Eyenovia Announces Launch and Commercial Availability of Clobetasol Propionate Ophthalmic Suspension 0.05% for Post-Operative Inflammation and Pain Following Ocular Surgery

Sep 26, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Launch and Commercial Availability of Clobetasol Propionate Ophthalmic Suspension 0.05% for Post-Operative Inflammation and Pain Following Ocular Surgery

Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization

Sep 9, 2024, 3:00 AM EDT - 1 year ago

Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization

Eyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S.

Sep 5, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S.

Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer

Sep 3, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer

Eyenovia Announces Closing of Public Offering

Aug 23, 2024, 11:42 AM EDT - 1 year ago

Eyenovia Announces Closing of Public Offering

Why Is Eye Disease Focused Eyenovia Stock Trading Higher On Thursday?

Aug 22, 2024, 2:20 PM EDT - 1 year ago

Why Is Eye Disease Focused Eyenovia Stock Trading Higher On Thursday?

Eyenovia Announces Pricing of $5.14 Million Public Offering

Aug 21, 2024, 9:29 AM EDT - 1 year ago

Eyenovia Announces Pricing of $5.14 Million Public Offering

Eyenovia, Inc. Announces Proposed Public Offering

Aug 20, 2024, 5:09 PM EDT - 1 year ago

Eyenovia, Inc. Announces Proposed Public Offering

Eyenovia, Inc. (EYEN) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 11:07 PM EDT - 1 year ago

Eyenovia, Inc. (EYEN) Q2 2024 Earnings Call Transcript

Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 12, 2024, 4:05 PM EDT - 1 year ago

Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Eyenovia to Report Second Quarter 2024 Results on Monday, August 12th

Aug 8, 2024, 7:00 AM EDT - 1 year ago

Eyenovia to Report Second Quarter 2024 Results on Monday, August 12th

Eyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S.

Aug 7, 2024, 5:11 PM EDT - 1 year ago

Eyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S.

Formosa Pharma and Eyenovia Announce Initiation of Co-Development of Clobetasol Propionate Ophthalmic Suspension, 0.05%, for the treatment of Acute Dry Eye Disease in United States

Aug 7, 2024, 8:00 AM EDT - 1 year ago

Formosa Pharma and Eyenovia Announce Initiation of Co-Development of Clobetasol Propionate Ophthalmic Suspension, 0.05%, for the treatment of Acute Dry Eye Disease in United States

Eyenovia & SGN Nanopharma Announce Collaboration Agreement to Develop Novel Treatment for Chronic Dry Eye Disease

Jul 30, 2024, 8:00 AM EDT - 1 year ago

Eyenovia & SGN Nanopharma Announce Collaboration Agreement to Develop Novel Treatment for Chronic Dry Eye Disease

Eyenovia and Senju Pharmaceutical Co., Ltd. Sign Collaboration Agreement for Potential New Treatment for Chronic Dry Eye Disease

Jul 23, 2024, 7:00 AM EDT - 1 year ago

Eyenovia and Senju Pharmaceutical Co., Ltd. Sign Collaboration Agreement for Potential New Treatment for Chronic Dry Eye Disease

NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities

Jul 1, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities

NBY

Sgershon88
Sgershon88 Dec. 4 at 5:59 PM
$HYPD For anyone not completely sure about the $HYPD (Dat) strategy or hyperliquid in general... Go do some research on $PURR.X which just went public yesterday. Over $800M devoted to buying and staking Hype coin... This is coming from someone that initially came into this company due to my interest in $EYEN. Got killed there obv, but have not sold my position and am now incredibly bullish on Hype.
0 · Reply
_www_larval_com_
_www_larval_com_ Dec. 4 at 3:27 PM
Look $HYPD has jumped 8% higher to 5% (~83Kv) moments ago, follow for more volatility.
0 · Reply
topstockalerts
topstockalerts Dec. 4 at 2:58 PM
Hyperion DeFi received nearly 2 million KNTQ tokens in a recent airdrop tied to Kinetiq’s token event. While noting limited trading history and expected volatility, the company cited a $0.145 trading price for KNTQ on December 3. Hyperion also secured rights to stake 28,888 HYPE tokens on the Kinetiq decentralized exchange and earn 10% of proportional fee revenue. It announced a partnership with Native Markets to support USDH, Hyperliquid’s native stablecoin, allocating 300,000 HYPE—its third DeFi monetization deal, expected to deliver returns above traditional staking. The company purchased an additional 150,000 HYPE, lifting its total holdings to 1.86 million, and expects adjusted revenue growth of 31% to 43% in Q4, with positive operating cash flow anticipated in 2026. $HYPD
0 · Reply
Diiiii
Diiiii Dec. 4 at 2:05 PM
$HYPD Something I've written about here several times has now been officially announced. Airdrop received at KNTQ's TGE. Although the share price continues to fall, I am once again convinced that HYPD will eventually become many times its current value.
0 · Reply
Pomer_Gile1
Pomer_Gile1 Dec. 4 at 2:05 PM
$HYPD Can anyone explain to me what this company actually does? Explain it as simply as possible
0 · Reply
Jwa68
Jwa68 Dec. 4 at 1:06 PM
$HYPD Nice news just out. https://www.globenewswire.com/news-release/2025/12/04/3199732/0/en/Hyperion-DeFi-Announces-Receipt-of-Kinetiq-Airdrop-Partnership-with-Native-Markets-and-Purchase-of-150-000-Additional-HYPE.html
0 · Reply
Jwa68
Jwa68 Dec. 3 at 11:59 PM
$HYPD https://www.linkedin.com/posts/ccndotcom_get-ready-for-our-next-interview-from-ugcPost-7401944359350448128-ZUGx?utm_source=share&utm_medium=member_android&rcm=ACoAAAEYKlkB4RqKdjXjN7IGB2MIOkTwWTUEzek
0 · Reply
URANIO_ARRICCHITO
URANIO_ARRICCHITO Dec. 3 at 9:03 PM
$HYPD The question is: 'Why ?'
1 · Reply
YorkMeister
YorkMeister Dec. 3 at 5:27 PM
$HYPD no SP volume, just silence, no buys of HYPX(?). If this wants to be a good proxy for investing in HYPX, it is not doing a good job at the start. Its MC is way below NAV. even after the crypto drop.
1 · Reply
949Jaguar123
949Jaguar123 Dec. 3 at 4:02 PM
$SONN What the deal with this , was at 4 d. couple days ago and now 1.26 , I am not in yet and holding $HYPD
1 · Reply
LoneBroker
LoneBroker Dec. 3 at 5:00 AM
$HYPD • $3.91 🐻 • RSI 36.41 • ATR 16.95% • vol↑ Support & Resistance — UPDATED 12/02/2025 5 Days | Support: $3.65 – $4.16 | Resistance: $4.09 – $4.59 20 Days | Support: $3.65 – $5.70 | Resistance: $4.09 – $6.48 60 Days | Support: $3.65 – $11.75 | Resistance: $4.09 – $15.00 Price behavior in HYPD suggests a tightening setup into key S/R zones. RSI at 36.4 reflects negative momentum while ATR% at 16.95% measures volatility. Watch the 5/20/60‑day support and resistance zones closely. 📌 RSI = momentum (0–100). >50 = strength, <50 = weakness 📌 ATR% = daily volatility (higher = bigger swings) 📌 Legend: 🐂 bullish • 🐻 bearish • 😐 neutral • vol↑ rising volume • vol↓ easing volume ⏳ Valid until: 4:00 PM ET
0 · Reply
Mike827
Mike827 Dec. 1 at 8:20 PM
$HYPD I’m guessing the hypd crypto coin tanking to below $30 now is due to everyone seeing the hypd crypto treasury share price being crushed into the toilet by incompetent management🤷🏿‍♀️🤷🏿‍♀️🤷🏿‍♀️🤷🏿‍♀️
1 · Reply
Mike827
Mike827 Dec. 1 at 8:04 PM
$HYPD is part of a new cutting edge crypto treasury strategy involve tanking the share price of the treasury company into the toilet 🤔🤔🤔
0 · Reply
Mike827
Mike827 Dec. 1 at 7:50 PM
$HYPD look on the bright side at least they can dilute the shares at these low prices and do a reverse split when dilution is complete.
0 · Reply
JohnApple73
JohnApple73 Dec. 1 at 5:38 PM
$HYPD I hope they are investing in more tokens behind the scenes. This might head down to lower 3’s without any news.
0 · Reply
Backer59
Backer59 Dec. 1 at 4:25 PM
$HYPD Great, just great. They tried to make chicken salad out of chicken shit. Guess what, it never works.😎
0 · Reply
SpencerF
SpencerF Dec. 1 at 3:11 PM
$HYPD still worth holding? Or is this a good place to dump?
1 · Reply
StonksToWatch
StonksToWatch Nov. 28 at 5:58 PM
$PRPH float runner into after hours? Monday news / call / webinar with CEO Bitcoin treasury approved Nov 24th 50M cash recievables CEO talks of 10x hidden value Q1 PT 0.90c $PW $DEFT $HYPD $GPUS
0 · Reply
YorkMeister
YorkMeister Nov. 28 at 2:39 PM
$HYPD 34m market cap, at least 60m NAV…
0 · Reply
LoneBroker
LoneBroker Nov. 28 at 9:28 AM
$MSFT $HYPD $IBIT
0 · Reply
mstan
mstan Nov. 27 at 1:52 AM
$YRD $HYPD
0 · Reply
YorkMeister
YorkMeister Nov. 26 at 9:33 AM
$HYPD Thanks for the link, Jung is articulate and careful, mature for his young age. The most important comment is that HYPD is using Hypertoken $HYPX to create revenue streams, it is not a simple capital appreciation treasury play like most others. Their 1.6m of hypx brings steady revenue - see Q3 results- and hypx is a finite pool which reduces over time through automatic buybacks. I hope he can buy more hypx at this low, I dont think it will last for long, not tied to BTC
1 · Reply